61 results for «1974»
61 results
Advancing transcatheter solutions for tricuspid valve disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...
From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions
21 May 2025 – From EuroPCR 2025
Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...
Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...
Focus on the right ventricle: patient selection and clinical outcomes after tricuspid valve intervention
16 Nov 2025 – From PCR London Valves 2025
Focused on the often-overlooked right ventricle, this session elucidates methods for accurate assessment of right ventricular function prior to transcatheter tricuspid valve interventions. It explores the role of right heart catheterisation in patient selection and timing, and evaluates long-term remodeling patterns post-procedure, providing critical insights for...
How to best image the atrioventricular valves?
14 May 2024 – From EuroPCR 2024
This session, in collaboration with the PCR Tricuspid Focus Group, aims to provide a comprehensive understanding of how to image the atrioventricular valves (mitral and tricuspid) to assess their anatomy and pathology. It covers the step-by-step evaluation of the mitral and tricuspid valves using transesophageal echocardiography...
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
PCR London Valves 2023 Welcome Ceremony
19 Nov 2023 – From PCR London Valves 2023
Experience the emotion of the opening ceremony of this 2023 edition of the PCR London Valves Course, which kicks off a rich 3-day programme from every point of view, and listen to the Course Directors announce the highlights and new features.
TMVR in challenging scenarios
20 May 2025 – From EuroPCR 2025
Navigate the challenges of transcatheter mitral valve replacement (TMVR) in complex clinical scenarios. This session explores treatment options when clipping is not feasible in a patient with heart failure and severe MR, management of multivalvular disease, advanced septal crossing techniques, and strategies for non-surgical candidates ineligible...
Transcatheter mitral valve interventions: procedural considerations
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations regarding transcatheter mitral valve interventions to learn how to select patients for each potential therapy and how to guide inside the cathlab.
What does the interventionist need to know from the imager?
21 Nov 2023 – From PCR London Valves 2023
Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...
PCR London Valves 2023 Closing Ceremony
21 Nov 2023 – From PCR London Valves 2023
Experience the highlights of PCR London Valve 2023 in this video retrospective, followed by insights from the Course Directors as they reflect on 3 dynamic and fruitful days that united 3,700 participants. Gratitude is extended to all contributors whose support was instrumental in the event's success....
Emerging options for patients with tricuspid regurgitation: a case-based discussion
19 May 2023 – From EuroPCR 2023
Want to view or revisit the key messages shared during this session on innovations in tricuspid regurgitation? Consult the slides of the topos presented by the speakers and discover what's essential to remember about the different entities of regurgitation, the potential and limitations of TTVR, patient...
PCR London Valves 2025 Welcome Ceremony
16 Nov 2025 – From PCR London Valves 2025
The PCR London Valves 2025 Welcome Ceremony marks the commencement of the conference, setting the stage for an immersive exploration of the latest advances and innovations in valvular heart disease management with a focus on transcatheter interventions.
Valve-in-valve - LIVE case
17 May 2023 – From EuroPCR 2023
Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function.
An Evolut Pro 26 was implanted in...
Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...
Primary mitral regurgitation: treatment options when the anatomy is complex
27 Nov 2022 – From PCR London Valves 2022
Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.
Reinventing the treatment of patients with tricuspid valve disease
28 Nov 2022 – From PCR London Valves 2022
This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.
Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Combined LAA closure and transcatheter mitral valve repair - LIVE Case
22 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...
